Media Coverage

Charles River to Accelerate Hit Discovery with AstraZeneca High-Throughput Deal

high-throughput screening

FierceBiotech

Charles River Laboratories has strengthened its high-throughput screening capabilities (HTS) by gaining access to technologies available at AstraZeneca's Centre for Lead Discovery in Cambridge, UK.

Read the full article